Table 4

Summary of AEs and laboratory outcomes meeting monitoring criteria

Graphic
  • *Vertigo.

  • †Spinal pain, hypertransaminasaemia.

  • ‡Peripheral swelling.

  • §Herpes zoster.

  • AE, adverse event; n, number of patients with events; TEAE, treatment-emergent adverse event.